Sarepta Therapeutics· @Sarepta · X·· 12 天前AI 评分12
AI 导读
在我们迎来美国 FDA 批准首款专门针对杜氏肌营养不良的疗法十周年之际，我们也向推动这一进步的社区致敬。感谢患者、家庭、倡导者和研究者，你们的贡献助力塑造了十余年的进展。 仅限美国居民
正文
As we mark the 10-year anniversary of the U.S. FDA approval of the first therapy specifically for Duchenne, we also celebrate the community that has helped drive progress. Thank you to the patients, families, advocates and researchers whose contributions have helped shape more than a decade of progress.
For U.S. residents
来源：Sarepta Therapeutics · x.com